Fig. 1. Schematic diagram illustrating the experimental protocol. CAO = coronary artery occlusion; CON = control group; DMSO = dimethyl sulfoxide (10 μl/g) intraperitoneally 35 min before coronary artery occlusion; DES = 1.0 minimum alveolar concentration desflurane for 15 min starting 30 min before coronary artery occlusion; DES + PIM-Inh.II = Pim-1 kinase inhibitor II (10 μg/g) intraperitoneally 5 min before desflurane (1.0 minimum alveolar concentration for 15 min); IPC = ischemic preconditioning (three cycles of 5 min ischemia–reperfusion each); IPC + PIM-Inh.II = Pim-1 kinase inhibitor II (10 μg/g) 5 min before ischemic preconditioning; PIM-Inh.II = Pim-1 kinase inhibitor II (10 μg/g) intraperitoneally 35 min before coronary artery occlusion.